FDA ANDA · ANDA086026

SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE

Sponsor: WATSON LABS

APPLICATION

ANDA086026

TYPE

ANDA

LATEST ACTION

1987-01-08

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

Discontinued

Products

SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDEDiscontinued

HYDROCHLOROTHIAZIDE 25MG, SPIRONOLACTONE 25MG · TABLET · ORAL

1987-01-08Manufacturing (CMC) · Supplement 16AP

1987-01-08Manufacturing (CMC) · Supplement 17AP

1987-01-08Manufacturing (CMC) · Supplement 15AP

1986-12-15Manufacturing (CMC) · Supplement 12AP

1986-12-15Manufacturing (CMC) · Supplement 13AP

1986-12-15Manufacturing (CMC) · Supplement 9AP

1986-07-03Manufacturing (CMC) · Supplement 14AP

1986-04-22Manufacturing (CMC) · Supplement 11AP

1984-08-03Manufacturing (CMC) · Supplement 8AP

1983-10-14Manufacturing (CMC) · Supplement 5AP

1983-04-08Manufacturing (CMC) · Supplement 4AP

1983-04-08Manufacturing (CMC) · Supplement 2AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.